S
Shuang Ye
Researcher at Shanghai Jiao Tong University
Publications - 89
Citations - 1590
Shuang Ye is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 62 publications receiving 996 citations.
Papers
More filters
Journal ArticleDOI
Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof‐of‐Concept Trial of Metformin
TL;DR: In this article, the effect of metformin on down-regulating the NET mtDNA-PDC-IFNα pathway was investigated, and a proof-of-concept trial was conducted in patients with mild or moderate lupus.
Journal ArticleDOI
Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
Shuang Ye,Xiao-Xiang Chen,Xiao-ye Lu,Mei-fang Wu,Yun Deng,Wen-qun Huang,Qiang Guo,Chengde Yang,Yue-ying Gu,Chunde Bao,Shunle Chen +10 more
TL;DR: Investigation of adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease with CADM-ILD found it to be a special phenotype of DM/PM and requires further investigation.
Journal ArticleDOI
Prognostic factors of lupus myelopathy
TL;DR: In this paper, 14 patients with lupus myelopathy (LM) from a centre were retrospectively studied, and 23 patients with other neuropsychiatric SLE (NPSLE) features were enrolled as a comparison group.
Journal ArticleDOI
Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
Ting Li,Li Guo,Zhiwei Chen,Liyang Gu,Fangfang Sun,Xiaoming Tan,Sheng Chen,Xiaodong Wang,Shuang Ye +8 more
TL;DR: The data indicated that the pirfenidone add-on may improve the prognosis of patients with subacute ILD related to CADM.
Journal ArticleDOI
Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.
TL;DR: In this article, the authors summarized the terminology, etiology and pathogenesis, clinical features and outcome, prognostic factors, and treatment of MDA5+DM-ILD in a review.